Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Chemotherapeutic Agent Toxicity|Pain|Peripheral Neuropathy|Recurrent Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Therapy-related Toxicity
Interventions: PROCEDURE: cryotherapy|OTHER: questionnaire administration|PROCEDURE: quality-of-life assessment|PROCEDURE: management of therapy complications|PROCEDURE: assessment of therapy complications
Sponsor: Northwestern University
Collaborators: National Cancer Institute (NCI)